Health Canada — Medical Devices · Canada · 2014-01-06 · Type II
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Archived by the issuing authority — kept for reference
Reported risk: Investigations have determined that this lot has an increased frequency of Troponin I results greater than 0.02 ng/mL for samples which are less than 0.02 ng/mL upon additional testing. Any questions about previously reported results, the recommendation would be to consult with your resident clinical expert or physician in the setting where the test was performed.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.